3 facts to know about Boston Scientific’s 2018 Q2 growth

Boston Scientific released its sales and profit growth results for the second quarter of 2018.

Advertisement

Here are three important facts:

1. Endoscopy profits were $442 million, up from $400 million over the same period in in 2017.

2. Second quarter sales were $2.490 billion, an increase of 10.3 percent on a reported basis , 8.6 percent on an operational basis and 7.9 percent on an organic basis, compared to the prior year.

3. The company reported GAAP earnings of $555 million or $0.40 per share, compared to GAAP earnings of $146 million or $0.11 last year, and achieved adjusted earnings per share of $0.41, compared to $0.32 last year.

More articles on GI and endoscopy:
GI leader to know: Dr. Justin Howard of University of Minnesota Medical Center
Exact Sciences, Lumendi & more — 4 GI company key notes
10 most-read GI stories in 2018

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.